Celestial Bio standalone Sep '15 sales at Rs 8.49 crore
Celestial Biolabs has reported a sales total income from operations of Rs 8.49 crore and a net profit of Rs 0.44 crore for the quarter ended Sep '15
November 11, 2015 / 05:59 PM IST
| Celestial Biolabs has reported a standalone total income from operations of Rs 8.49 crore and a net profit of Rs 0.44 crore for the quarter ended Sep '15. | | For the quarter ended Sep 2014 the standalone total income from operations was Rs 7.47 crore and net profit was Rs 0.33 crore. | | Celestial Bio shares closed at 19.60 on November 09, 2015 (NSE) and has given -72.28% returns over the last 6 months and -33.22% over the last 12 months. |
|
| | Celestial Biolabs | | Standalone Quarterly Results | -------- in Rs. Cr. -------- |
|
| Sep '15 | Jun '15 | | | Sep '14 | | Net Sales/Income from operations | 8.49 | 8.03 | | | 7.47 | | Other Operating Income | -- | -- | | | -- | | Total Income From Operations | 8.49 | 8.03 | | | 7.47 | | EXPENDITURE | | | | | | | Consumption of Raw Materials | 3.04 | 2.12 | | | 1.43 | | Purchase of Traded Goods | 1.62 | 1.76 | | | 2.61 | | Increase/Decrease in Stocks | -1.25 | -1.03 | | | -1.06 | | Power & Fuel | -- | -- | | | -- | | Employees Cost | 0.28 | 0.26 | | | 0.25 | | Depreciation | 1.77 | 0.51 | | | 1.25 | | Excise Duty | -- | -- | | | -- | | Admin. And Selling Expenses | -- | -- | | | -- | | R & D Expenses | -- | -- | | | -- | | Provisions And Contingencies | -- | -- | | | -- | | Exp. Capitalised | -- | -- | | | -- | | Other Expenses | 2.03 | 3.45 | | | 2.17 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 1.01 | 0.96 | | | 0.83 | | Other Income | -- | -- | | | -- | | P/L Before Int., Excpt. Items & Tax | 1.01 | 0.96 | | | 0.83 | | Interest | 0.48 | 0.49 | | | 0.43 | | P/L Before Exceptional Items & Tax | 0.54 | 0.47 | | | 0.40 | | Exceptional Items | -- | -- | | | -- | | P/L Before Tax | 0.54 | 0.47 | | | 0.40 | | Tax | 0.10 | 0.09 | | | 0.07 | | P/L After Tax from Ordinary Activities | 0.44 | 0.38 | | | 0.33 | | Prior Year Adjustments | -- | -- | | | -- | | Extra Ordinary Items | -- | -- | | | -- | | Net Profit/(Loss) For the Period | 0.44 | 0.38 | | | 0.33 | | Equity Share Capital | 18.56 | 18.56 | | | 17.35 | | Reserves Excluding Revaluation Reserves | 62.25 | 62.25 | | | 68.25 | | Equity Dividend Rate (%) | -- | -- | | | -- | | EPS Before Extra Ordinary | | | | | | | Basic EPS | 0.24 | 0.21 | | | 0.19 | | Diluted EPS | 0.24 | 0.21 | | | 0.19 | | EPS After Extra Ordinary | | | | | | | Basic EPS | 0.24 | 0.21 | | | 0.19 | | Diluted EPS | 0.24 | 0.21 | | | 0.19 | | Public Share Holding | | | | | | | No Of Shares (Crores) | 1.14 | 1.14 | | | 1.11 | | Share Holding (%) | 61.19 | 61.19 | | | 63.88 | | Promoters and Promoter Group Shareholding | | | | | | | a) Pledged/Encumbered | | | | | | | - Number of shares (Crores) | -- | -- | | | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | | | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | | | -- | | b) Non-encumbered | | | | | | | - Number of shares (Crores) | 0.72 | 0.72 | | | 0.63 | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | 100.00 | 100.00 | | | 100.00 | | - Per. of shares (as a % of the total Share Cap. of the company) | 38.81 | 38.81 | | | 36.12 | | Source : Dion Global Solutions Limited |
|
_2020091018165303jzv.jpg "Decoding The World Of ETF")
Republic Day 2021 parade: What will be different this year due to COVID-19 impact? Watch more 
Explained | How will Wall Street fare under President Joe Biden? Watch more 
TCS becomes the most valued IT firm in market cap surpassing Accenture Watch more 
Indian Army soldiers push back Chinese troops in Sikkim sector; both sides sustain injuries Watch more 
